Index

Hormones in Obstetrics and Gynaecology Vijay Zutshi, Asmita Muthal Rathore, Kamla Sharma

GYNAECOLOGY
CHAPTER 1:Amenorrhea
- INTRODUCTION
- PRIMARY AMENORRHEA
- IMPORTANT DIAGNOSTIC INVESTIGATIONS
  - Patient with Normal Secondary Sexual Characters
- PATIENTS WITH ABSENT SECONDARY SEXUAL CHARACTERS
- TREATMENT
  - Goals of Therapy
- FERTILITY PROSPECTS
- SECONDARY AMENORRHEA
  - Diagnosis
- TREATMENT OF SECONDARY AMENORRHEA
- CONCLUSION
- KEY POINTS
CHAPTER 2:Hormones in Hirsutism and Polycystic Ovarian Syndrome
- HIRSUTISM
- POLYCYSTIC OVARY SYNDROME (PCOS)
- KEY POINTS
CHAPTER 3:Hormones in Infertility
- INTRODUCTION
  - Ovulatory Deficiencies Defined by WHO are:
- MANAGEMENT
- GONADOTROPIN THERAPY
- ADJUNCTIVE THERAPIES
- PULSATILE GNRH THERAPY
  - Indications
- CONCLUSION
- KEY POINTS
CHAPTER 4:Dysfunctional Uterine Bleeding: Hormonal Management
- INTRODUCTION
- PATHOPHYSIOLOGY OF DUB
- ROUTINE WORKUP OF PATIENT OF DUB
- GENERAL MEASURES IN TREATMENT OF DUB
- MEDICAL MANAGEMENT IN DUB
- CHOICE OF THERAPY
- PARAMETERS OF SUCCESS AND LONG-TERM FOLLOW-UP
- KEY POINTS
CHAPTER 5:Role of Hormones in the Treatment of Endometriosis
- INTRODUCTION
- HORMONES USED FOR THE ALLEVIATION OF PAIN
- PERIOPERATIVE HORMONAL TREATMENT
- HORMONES FOR THE TREATMENT OF ENDOMETRIOSIS-ASSOCIATED INFERTILITY
  - Hormone Replacement Therapy (HRT)
- CONCLUSION
- KEY POINTS
CHAPTER 6:Dysmenorrhea and Premenstrual Syndrome: Hormonal Management
- DYSMENORRHEA
- HORMONES
- OTHER MODES OF THERAPY OF DYSMENORRHEA
- KEY POINTS
- PREMENSTRUAL SYNDROME
- HORMONAL THERAPY IN PMS
- SURGICAL TREATMENT IN PMS
- KEY POINTS
CHAPTER 7:Hormones in Malignancy
- INTRODUCTION
- ENDOMETRIAL CARCINOMA
- HORMONE THERAPY FOR OVARIAN CARCINOMA
- HORMONES UNDER SPECIAL CIRCUMSTANCES
- KEY POINTS
OBSTETRICS
CHAPTER 8:Role of Progestogens and hCG in Threatened and Recurrent Abortion
- KEY POINTS
CHAPTER 9:Micronized Progesterone: Uses in Pregnancy
- INTRODUCTION
- MICRONIZED PROGESTERONE
- USES OF MICRONIZED PROGESTERONE
- CONCLUSION
- KEY POINTS
HRT
CHAPTER 10:Evaluation and Follow-up of a Case Receiving Hormone Replacement Therapy
- INTRODUCTION
  - Principles of Estrogen Administration
  - Pretreatment Assessment
- HISTORY
- ENDOMETRIAL BIOPSY/ENDOMETRIAL SAMPLING
  - Progesterone Challenge Test
    - Hormone Profile
    - Lipid Profile
- COAGULATION PROFILE
  - Indications
  - Investigations
- LIVER FUNCTION TESTS
- BIOCHEMICAL MARKERS16
- MAMMOGRAPHY11
  - Indications
- U.S.G. PELVIS
- ENDOMETRIAL BIOPSY
  - Indications
- ENDOMETRIAL ASPIRATION11
- PROGESTERONE CHALLENGE TEST17
- CURRENT CONTRAINDICATIONS FOR HRT
- HRT—NEW INDICATIONS
- HRT—NEUTRAL SITUATIONS
- FOLLOW-UP ASSESSMENT11
- ROLE OF HYSTEROSCOPY
  - Vaginal pH as a Marker for Menopausal Status19
  - Stopping of HRT
- CONCLUSION
- KEY POINTS
CHAPTER 11:Hormone Replacement Therapy as Prophylaxis
- INTRODUCTION
  - Consequences of Estrogen Deficiency
    - Short Term—
  - Long-term Sequelae
- OSTEOPOROSIS
  - Prevention and Treatment of Osteoporosis
- CARDIOVASCULAR DISEASE
- ALVEOLAR TOOTH LOSS
- VISION DISORDERS
- COLON CANCER
- EFFECT ON COGNITIVE FUNCTION
- UROGENITAL ATROPHY
- CONCLUSION
- KEY POINTS
CHAPTER 12:Hormone Replacement Therapy as Treatment
- INTRODUCTION
- ENDOCRINOLOGY
  - Gonadotropins
    - Symptoms
- HORMONE REPLACEMENT THERAPY (HRT)
  - Indications for HRT
- PREMATURE OVARIAN FAILURE
- POST MENOPAUSAL SYMPTOMS
- OSTEOPOROSIS
- PRIMARY AMENORRHOEA
- ADDBACK THERAPY
- NON-ORAL DELIVERY SYSTEM
- SELECTION OF HORMONE AND REGIMEN
- CONTRAINDICATIONS
- COUNSELING AND PRETREATMENT ASSESSMENT
- KEY POINTS
CHAPTER 13:Controversies in Hormone Replacement Therapy
- INTRODUCTION
- HRT AND ENDOMETRIOSIS
- HRT AND TRANSCERVICAL RESECTION OF ENDOMETRIUM (TCRE)
- HRT AND OVARIAN CANCER
- HRT AND BREAST CANCER
- HRT AND MEDICAL CONDITIONS
- CONCLUSION
- KEY POINTS
CHAPTER 14:Hormone Replacement Therapy in 2004
- CARDIOVASCULAR RISKS
- THROMBOEMBOLISM
- CEREBROVASCULAR DISEASE
- OSTEOPOROSIS
- BREAST CANCER
- COLORECTAL CANCER
- ENDOMETRIAL CANCER
- OVARIAN CANCER
- CONCLUSION
- KEY POINTS
CONTRACEPTION
CHAPTER 15:Oral Contraceptives
- INTRODUCTION
- TYPES OF ORAL CONTRACEPTIVES
- COMBINED PILLS
- PROGESTERONE-ONLY PILLS
- KEY POINTS
CHAPTER 16:Combined Oral Contraceptives in High-risk Women
- INTRODUCTION
- CARDIOVASCULAR DISEASE
- BREAST CARCINOMA
- DIABETES MELLITUS
  - The WHO Categories for Temporary Methods (Table 16.1)
- KEY POINTS
CHAPTER 17:Injectable Contraceptives, Implants and Long-acting Progestogens
- INTRODUCTION
- SIDE EFFECTS
- INDICATIONS FOR INJECTABLE CONTRACEPTION
  - Monthly Injectables as DMPA and NETEN
- LONG-ACTING SUBDERMAL PROGESTOGEN IMPLANTS
- CONCLUSION
- KEY POINTS
CHAPTER 18:Emergency Contraception
- INTRODUCTION
- INDICATIONS OF EMERGENCY CONTRACEPTION
- HIGH-DOSE ESTROGENS
- ESTROGEN AND PROGESTIN COMBINATION PILL
- INTRAUTERINE CONTRACEPTIVE DEVICE (IUCD)
- PROGESTOGENS
  - Advantages
- DANAZOL
  - Contraindications
- ANTIPROGESTINS
- CENTCHROMAN
  - Side Effects
- MISCELLANEOUS
- COUNSELING BEFORE EC
- RECOMMENDATIONS
- COMMON QUERIES CONCERNED WITH PRESCRIBERS OF EMERGENCY CONTRACEPTIVE PILLS6
- LEGAL, ETHICAL AND SOCIAL CONSIDERATIONS IN PRESCRIBING EC
- KEY POINTS
CHAPTER 19:Hormonal Contraception: What's New
- INTRODUCTION
- HORMONAL IUCDS
- CONTRACEPTIVE RINGS
- CONTRACEPTIVE PATCHES
- KEY-POINTS

INDEX

TOC
Index

Chapter Notes